NCT05677594View on ClinicalTrials.gov

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Neurofibromatosis 1Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis)Atypical Neurofibroma
Interventions
DIAGNOSTIC_TEST

Whole Body Magnetic Resonance Imaging

Magnetic resonance imaging of the entire body from skull base through distal thighs/knees without contrast material

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Neurofibromatosis Therapeutic Acceleration Program

UNKNOWN

lead

Johns Hopkins University

OTHER